INTRODUCTION {#S1}
============

Integrins are the major cell surface receptors for adhesion to extracellular matrix (ECM), and they activate intracellular signaling pathways that control a wide variety of cell functions, including cell polarity, proliferation, survival, and motility ([@R27]). Numerous studies have demonstrated roles for keratinocyte integrins in mediating epidermal function during both normal and pathological skin remodeling processes, including wound healing, tumorigenesis, tumor invasion and various skin diseases ([@R26]; [@R37]; [@R39]; [@R57]). However, roles for integrins in regulating genes that control these processes remain unclear. Integrin α3β1 is highly expressed in the epidermis where it mediates keratinocyte adhesion to laminin-332 (LN-332) in the basement membrane ([@R10]; [@R18]; [@R31]). α3β1 is also expressed highly in wound epidermis ([@R37]), and in squamous cell carcinoma (SCC) where it contributes to tumor growth, invasion and metastasis ([@R29]; [@R48]). Indeed, numerous studies using primary or immortalized keratinocytes have identified roles for α3β1 in a range of cell functions important for wound healing and tumor progression, including cell polarization and migration, ECM organization, invasion, survival, and paracrine stimulation of endothelial cells ([@R12]; [@R13]; [@R17]; [@R28]; [@R31]; [@R32]; [@R38]; [@R40]). Furthermore, in vivo studies using global or epidermis-specific α3 knockout mice have identified roles for α3β1 in basement membrane organization and epidermal-dermal adhesion ([@R19]; [@R36]), hair follicle morphogenesis ([@R15]), wound reepithelialization ([@R38]), induction of wound angiogenesis ([@R40]), and tumor growth ([@R1]; [@R33]).

Many α3β1-mediated keratinocyte functions can be attributed to its roles in mediating cell spreading, migration, and cytoskeletal reorganization ([@R31]). However, α3β1 also regulates expression of secreted proteases or growth factors in immortalized keratinocytes that can alter ECM or stimulate other cellular compartments, thereby allowing epidermal cells to modify the wound or tumor microenvironment ([@R28]; [@R40]). In the current study, we sought to identify α3β1-dependent changes in global gene expression that may contribute to ECM remodeling or invasive properties of immortalized keratinocytes. Microarray analysis and quantitative PCR (qPCR) validation revealed substantial changes in gene expression in immortalized mouse keratinocytes (MK cells) that lack α3β1 due to null mutation of the *Itga3* gene, which encodes the α3 subunit. Many of these α3β1-responsive genes are involved in normal or pathological skin remodeling, including wound healing and epidermal carcinogenesis, and several encode proteins with known roles in modulating the skin microenvironment through changes in ECM organization, ECM proteolysis, or paracrine stimulation of other cells. One such protein, fibulin-2, is a secreted matricellular protein that can bind several ECM proteins including perlecan, fibrillin-1, aggrecan, fibronectin, and γ2 chain-containing laminins ([@R55]; [@R43]). Another example is SPARC (secreted protein acidic and rich in cysteine), an ECM-associated protein with roles in tumor angiogenesis, invasion and metastasis ([@R4]). Interestingly, custom qPCR arrays did not reveal statistically significant differences in most genes upon deletion of α3β1 from non-immortalized, primary keratinocytes, suggesting that α3β1-dependent gene regulation was acquired by immortalized keratinocytes, as we described previously for MMP-9 ([@R21]; [@R33]). However, while α3β1-dependent regulation of fibulin-2 was observed in cells immortalized by either SV40 large T antigen or p53-null mutation, α3β1-dependence of SPARC and other genes was influenced by the immortalizing genetic lesion. siRNA-mediated suppression of fibulin-2 reduced invasion of p53-null MK cells, consistent with pro-invasive/pro-metastatic roles for fibulin-2 in some cancers ([@R7]; [@R52]). However, stable knockdown of fibulin-2 in RasV12-transformed keratinocytes did not inhibit α3β1-dependent tumor growth in a subcutaneous allograft model. Taken together, these findings support a role for integrin α3β1 in the regulation of fibulin-2 and other genes that contribute to the invasive properties of transformed keratinocytes.

RESULTS {#S2}
=======

Microarrays of immortalized keratinocytes reveal α3β1-dependent changes in genes that modulate the tumor microenvironment {#S3}
-------------------------------------------------------------------------------------------------------------------------

We used Affymetrix whole genome arrays (Mouse Exon ST 1.0) to compare global gene expression between MK cells that were derived from either wild-type mice (MK+/+ cells) or mice that lack α3β1 (MK−/− cells), and were immortalized with SV40 Large T antigen (LTAg) ([@R21]). MK cells were cultured in low calcium (0.05 mM CaCl~2~) on collagen-coated plates, since under these conditions they deposit abundant LN-332 regardless of α3β1 expression ([@R21]). Initially, we identified 739 genes that increased or decreased by at least 1.5-fold in MK−/− cells compared to MK+/+ cells. However, some differences could be due to clonal variations that arose during expansion of these cell lines ([@R21]). Therefore, we narrowed our list of candidate genes to those that changed in MK−/− cells but were rescued to original expression levels after restoring α3β1 in this line (i.e., MK−/−:hα3 cells) by stable transfection with human α3 ([@R28]). This analysis identified a subset of 252 genes that were rescued by α3β1, most of which were restored to within 1.5-fold of their expression in MK+/+ cells. Select genes that fulfilled these initial criteria are shown in [Figure S1](#SD1){ref-type="supplementary-material"}. From genes that fit this pattern, 86 were validated as α3β1-dependent using customized qPCR arrays to compare expression in MK+/+ cells versus either MK−/− cells or MK−/−:hα3 cells. A selection of validated genes that fulfilled these final criteria are shown in [Figures 1a and 1b](#F1){ref-type="fig"}, and listed in [Figure 1c](#F1){ref-type="fig"}.

Among validated α3β1-dependent genes were many that contribute to ECM remodeling in tumors or wounds ([Fig. 1](#F1){ref-type="fig"}), including ECM-associated proteins (e.g., fibulin-2, SPARC, thrombospondin-2) and ECM proteases/sulfatases or their inhibitors (e.g., sulf-2, serpine2, serpinB2/PAI-2, Pi15). α3β1-dependent regulation of fibulin-2 is particularly intriguing since this protein can bind the γ2 chain of laminin-332, the major ECM ligand of α3β1 ([@R56]), and we recently implicated fibulin-2 in α3β1-dependent epidermal functions during development and wound healing ([@R36]). Although SPARC is overexpressed in esophageal SCC ([@R11]; [@R45]), the literature regarding SPARC function in cancer is controversial, and both pro-tumorigenic and tumor suppressor functions have been described ([@R4]; [@R8]; [@R24]; [@R30]; [@R35]). Expression of the protease inhibitor Pi15 decreased most substantially in α3β1-deficient cells on both gene microarrays and qPCR arrays. While the functional impact of this change is not known, it is noteworthy that altered Pi15 expression has been associated with wound healing ([@R47]). α3β1 deletion also altered expression of transcriptional regulators, such as mecom and cited2. Of note, cited2 is a transcriptional coactivator that induces MMP-9 gene expression in response to TGF-β ([@R14]), which could conceivably contribute to cooperative induction of MMP-9 mRNA by α3β1 and TGFβ that we previously described in MK cells ([@R32]).

α3β1 also regulated genes that encode factors for paracrine stimulation of other cell types (e.g., kitl, Prl2c2/Prl2c3). Indeed, members of the mitogen-regulated protein (MRP)/proliferin family were among the α3β1-dependent genes detected by microarray ([Fig. S1](#SD1){ref-type="supplementary-material"}) and validated by qPCR ([Fig. 1](#F1){ref-type="fig"}). This finding validates our approach to identify α3β1-dependent genes, as it is consistent with our previous report that α3β1-dependent MRP-3/Prl2c3 gene expression promotes MK cell crosstalk to endothelial cells ([@R40]). Nevertheless, not all α3β1-dependent genes were revealed by the initial microarray, since α3β1-dependent MMP-9 expression described previously ([@R28]) was confirmed by qPCR ([Fig. 1](#F1){ref-type="fig"}) but not detected by gene microarray.

α3β1-dependent gene regulation is associated with keratinocyte immortalization {#S4}
------------------------------------------------------------------------------

Our earlier work showed that α3β1-dependent MMP-9 gene expression is acquired during keratinocyte immortalization ([@R21]; [@R33]). To determine whether α3β1-dependent regulation of other genes is similarly acquired by immortalized cells, we utilized our custom qPCR array to compare gene expression in freshly isolated primary keratinocytes from neonatal mice that either express α3β1 (control mice) or lack α3β1 in epidermis (α3eKO mice) due to deletion of a floxed *Itga3* allele by Cre recombinase under control of the keratin-14 promoter ([@R40]). α3 protein was readily detected by immunoblot of primary cultures from control mice (albeit at variable levels) but was uniformly undetectable in cultures from α3eKO mice ([Fig. S2a](#SD1){ref-type="supplementary-material"}). Interestingly, microarrays of cells isolated from three individual mice of each genotype revealed no statistically significant differences between control and α3eKO cells for genes that had been identified as α3β1-responsive in immortalized MK cells ([Fig. S2b](#SD1){ref-type="supplementary-material"}). Notably, we observed a trend towards decreased expression of fibulin-2 and thrombospondin-2 in α3eKO primary cells, although the magnitude was variable and did not reach statistical significance. These findings indicate that α3β1-dependent regulation of most genes was acquired by immortalized keratinocytes.

α3β1-dependent gene regulation is influenced by the genetic lesion that drives keratinocyte immortalization {#S5}
-----------------------------------------------------------------------------------------------------------

To determine how α3β1-mediated gene regulation observed in LTAg-immortalized MK cells is influenced by other genetic lesions that drive immortalization/transformation, we utilized an independently derived set of mouse keratinocyte lines ([Fig. 2a](#F2){ref-type="fig"}). IMK cells are immortalized by p53 knockout and either express α3β1 (IMKα3+/+) or lack α3β1 (IMKα3−/−), as described ([@R33]). TMK cells are transformed, tumorigenic derivatives of IMK cells that were stably transduced with oncogenic H-RasV12 ([@R33]). Since p53 loss and oncogenic activation of H-Ras are common genetic lesions in cutaneous SCC ([@R6]; [@R60]), these IMK and TMK lines provide a useful model for assessing integrin-dependent gene expression in SCC progression. qPCR showed dramatically reduced fibulin-2 mRNA in IMKα3−/− cells compared with IMKα3+/+ cells ([Fig. 2b](#F2){ref-type="fig"}), indicating similar α3β1-dependent regulation to that in LTAg-immortalized MK cells ([Fig. 1](#F1){ref-type="fig"}). Other genes that were α3β1-dependent in both p53-null and LTAg-immortalized keratinocytes included MMP-9, Serpine2, Sulf2, and Mt4 (data not shown) ([@R21]; [@R33]). In contrast, SPARC and certain other genes that were α3β1-dependent in LTAg-immortalized cells were not α3β1-dependent in p53-null IMK cells ([Fig. 2c](#F2){ref-type="fig"}, and data not shown), indicating an influence of the genetic lesion that initiates immortalization. RasV12-transformed TMK cells retained expression patterns for fibulin-2 and SPARC that were observed in the parental IMK cells ([Fig. 2d, e](#F2){ref-type="fig"}).

Suppression of fibulin-2 reduces invasion of RasV12-transformed keratinocytes {#S6}
-----------------------------------------------------------------------------

Fibulin-2 can be expressed as a monomer or a disulfide-linked homodimer. The monomer can range in size from 160 kDa to 195 kDa due to variations in mRNA splicing, post-translational modification, or proteolysis ([@R43]; [@R49]; [@R58]; [@R53]). Immunoblots of non-reduced lysates from LTAg-immortalized MK cells with anti-fibulin-2 revealed a \~160 kDa band corresponding to the monomeric form, as well as a high molecular weight band corresponding to the \~375 kDa dimeric form ([Fig. 3a](#F3){ref-type="fig"}, non-reducing). As expected, only the monomeric form was detected on a reducing blot ([Fig. 3a](#F3){ref-type="fig"}, reducing). Consistent with our qPCR results, absence of α3β1 was associated with reduced expression of total fibulin-2 protein, defined as the sum of dimeric and monomeric forms ([Fig. 3a, b](#F3){ref-type="fig"}). Similarly, total fibulin-2 protein was reduced in both p53-null immortalized IMK cells and RasV12-transformed TMK cells that lack α3β1 ([Fig. 3c](#F3){ref-type="fig"}). Notably, IMK cells and TMK cells each showed considerable variation in the relative abundance of monomeric and dimeric fibulin-2 over several experiments. While the reason for this variation is unclear, it could be due to sensitivity of disulfide-linkage to subtle differences in culture conditions.

Mutations in p53 and Ras are associated with increased invasion ([@R9]; [@R44]), and both IMKα3−/− cells and TMKα3−/− cells showed reduced invasion through Matrigel compared with their α3-expressing counterparts ([Fig. S3](#SD1){ref-type="supplementary-material"}) ([@R33]). Since fibulin-2 may promote invasion in some cancers ([@R7]; [@R52]), we reasoned that α3β1-mediated invasion might require fibulin-2. We showed that treatment of α3β1-expressing IMK cells or TMK cells with either of two siRNAs to knockdown fibulin-2 ([Fig. 4a, b](#F4){ref-type="fig"}) significantly reduced invasion compared to treatment with control siRNA ([Fig. 4c, d](#F4){ref-type="fig"}). Thus, α3β1-dependent fibulin-2 expression enhances invasion of keratinocytes that harbor a loss-of-function p53 mutation and oncogenic RasV12.

Stable knockdown of fibulin-2 in tumorigenic TMKα3+/+ cells does not inhibit in vivo tumor growth {#S7}
-------------------------------------------------------------------------------------------------

We previously showed that TMKα3−/− cells display reduced subcutaneous tumor growth compared to TMKα3+/+ cells ([@R33]), consistent with a recently described pro-tumorigenic role for α3β1 in SCC development ([@R48]). To determine whether fibulin-2 facilitates α3β1-dependent tumor growth, we stably transduced TMKα3+/+ cells with lentiviral vectors expressing two independent fibulin-2 shRNAs, each of which efficiently suppressed fibulin-2 as determined by qPCR (data not shown) and immunoblot ([Fig. 5a](#F5){ref-type="fig"}). Following subcutaneous injection into nude mice, TMKα3+/+ cells transduced with control shRNA showed significantly faster tumor growth than did TMKα3−/− cells transduced with the same shRNA ([Fig. 5b](#F5){ref-type="fig"}), confirming α3β1-dependent tumor growth in this allograft model ([@R33]). However, stable transduction of TMKα3+/+ cells with either fibulin-2-targeting shRNA did not reduce tumor growth compared with control shRNA ([Fig. 5b](#F5){ref-type="fig"}), indicating that suppression of fibulin-2 does not inhibit α3β1-mediated tumor growth of TMK cells. Although we observed that TMKα3+/+ cells transduced with one fibulin-2-targeting shRNA formed larger tumors than control TMKα3+/+ cells, we did not observe this effect with the other fibulin-2-targeting shRNA.

Since we previously showed that α3β1-dependent MMP-9 expression is important for TMKα3+/+ cell invasion ([@R33]), and some fibulins (including fibulin-2) have been associated with MMP expression ([@R16]; [@R42]), we performed gelatin zymography to assess MMP-9 secretion in the TMK variants. TMKα3−/− cells secreted substantially less MMP-9 compared with TMKα3+/+ cells ([Fig. 5c](#F5){ref-type="fig"}) ([@R33]). However, MMP-9 secretion was not altered by shRNA-mediated suppression of fibulin-2 ([Fig. 5c](#F5){ref-type="fig"}), suggesting that MMP-9 and fibulin-2 each have necessary but independent roles in α3β1-mediated TMK cell invasion.

DISCUSSION {#S8}
==========

It is well established that integrins can regulate the ability of tumor cells to modulate the ECM of the tumor microenvironment through regulation of proteases or expression of ECM proteins ([@R39]; [@R59]). In particular, integrin α3β1 has long been known to regulate expression or activities of extracellular proteases involved in tumor progression or wound healing, including MMPs and the urokinase plasminogen activator (uPA) system ([@R25]; [@R28]; [@R33]; [@R41]; [@R54]). Here, we have identified a role for α3β1 in regulating keratinocyte genes that encode ECM proteins, extracellular proteases or their inhibitors, growth factors, or transcriptional regulators, many of which are known to contribute directly or indirectly to microenvironmental modifications of cutaneous tumors or wounds. Interestingly, some genes (e.g., fibulin-2 and MMP-9) showed similar α3β1-dependent expression in cells immortalized by either LTAg expression or p53 knockout, while other genes (e.g., SPARC) show dissimilar regulation in these two cases. Taken together, our findings suggest that α3β1-mediated regulation of some target genes is influenced by the genetic lesion that triggers immortalization.

Interestingly, most genes that showed α3β1-dependent regulation in immortalized keratinocytes were not altered in primary, non-immortalized keratinocytes by deletion of α3β1, suggesting that this regulation was acquired as part of the immortalized phenotype. The acquisition of α3β1-dependent regulation of fibulin-2 and other genes in immortalized MK cells resembles that which we reported previously for the MMP-9 gene ([@R21]), which we subsequently linked to invasive potential of oncogenically transformed MK cells ([@R33]). Our current findings suggest an important role for α3β1 in mediating adaptive changes in gene expression that facilitate carcinogenesis, where the exact profile of acquired gene changes may depend on the oncogenic or tumor suppressor mutations involved.

There is a wide range of potential mechanisms whereby integrins may regulate tumor cell behavior ([@R39]). Our results suggest that α3β1-mediated induction of fibulin-2 in transformed keratinocytes contributes to invasive behavior. Roles for fibulins in cancer are complex, and family members have been described to have either tumor suppressive or oncogenic roles, and in some cases both ([@R23]; [@R51]). For example, fibulin-1 has both tumor suppressive and tumor promoting functions, and fibulin-4 may be oncogenic ([@R23]; [@R51]). Fibulin-5 may also have cell type-specific effects on cell growth and angiogenesis ([@R2]; [@R51]). Although little is known about roles of fibulin-2 in cancer progression, it has been described both as a promoter of malignancy and a tumor suppressor ([@R42]). Indeed, fibulin-2 has been associated with metastasis of adenocarcinoma ([@R46]) and malignant progression of lung adenocarcinoma ([@R7]). On the other hand, loss of fibulin-2 has been associated with breast cancer progression ([@R58]) and Kaposis sarcoma ([@R3]), and one study described anti-angiogenic and tumor suppressive roles for fibulin-2 in nasopharyngeal carcinoma ([@R34]). Stromal cells also deposit fibulin-2 into the ECM, which may influence tumor progression. Importantly, our MK cell model allowed us to focus on the functional importance of fibulin-2 that is expressed by immortalized/transformed keratinocytes. Interestingly, suppression of fibulin-2 in transformed keratinocytes reduced invasion, but not in vivo tumor growth, suggesting that keratinocyte-derived fibulin-2 is dispensable at early stages of tumorigenesis but may become important at later stages of invasion.

In summary, the ability of α3β1 in immortalized/transformed keratinocytes to regulate expression of fibulin-2, as well as other genes associated with ECM remodeling, supports an important role for this integrin in SCC development and invasion. This regulation may be related to a role for α3β1 that we recently described in epidermis, where its ability to regulate fibulin-2 appears important for proper skin development and wound healing ([@R36]). Given the similarities in tissue remodeling that occurs during skin carcinogenesis and wound healing ([@R5]; [@R22]; [@R50]), it will be interesting to determine whether other α3β1-dependent genes in immortalized keratinocytes are similarly regulated in wound keratinocytes.

MATERIALS AND METHODS {#S9}
=====================

Cell culture {#S10}
------------

LTAg-immortalized MK cell lines were derived from wild-type (MK+/+) or α3-null (MK−/−) neonatal mice harboring an SV40 large T antigen transgene, as described ([@R21]). MK−/−:hα3 cells were derived from MK−/− cells stably transfected with human α3 ([@R28]). p53-deficient IMKα3+/+ and IMKα3−/− cells were similarly derived from wild-type or α3-null neonatal mice, respectively, harboring a p53-null mutation ([@R33]). To generate transformed TMK cells, IMKα3+/+ or IMKα3−/− cells were transduced with a retrovirus encoding oncogenic RasV12 ([@R33]). Epidermis-specific α3 knockout mice (α3eKO mice) are homozygous for a floxed α3 allele (α3^flx/flx^) and express a Cre recombinase transgene under control of the keratin 14 promoter (K14-Cre), as described ([@R40]). Primary keratinocytes were isolated from α3eKO mice (genotype K14-Cre:α3^flx/flx^) or control littermates lacking K14-Cre (genotype α3^flx/flx^) using established protocols ([@R21]). Culture conditions for primary keratinocytes and MK cell lines were described elsewhere ([@R21]; [@R33]).

RNA isolation, gene microarrays and qPCR {#S11}
----------------------------------------

Total RNA was isolated using RNeasy Plus isolation kit (Qiagen, Valencia, CA), and quality was confirmed on an Agilent Bioanalyzer. Affymetrix whole genome arrays (Mouse Exon ST 1.0) include probe coverage over the full length of mouse coding sequences. Each of the 28,853 genes is represented on the array by replicate (27 each) probes spanning each gene. Microarray data acquisition and processing was performed using Affymetrix Command Console Operating Software, and the quality of array data assessed using metrics derived with Affymetrix Expression Console (Intensity Distribution, Mean Signal, BAC Spike, polyA Spike, Pos Vs Neg AUC, Mad Residual Signal, RLE Mean, and Hierarchical Clustering of Samples). Data was imported into GeneSpring v11 for advanced analysis. First, raw data was quantile-normalized using the PLIER algorithm, subjected to a Principal component analysis to again remove outliers and filtered on expression values to exclude probe sets in the bottom 20th percentile of expression across all conditions. Normalized data were subjected to ANOVA (P\<0.05) incorporating a multiple correction factor (Benjamini-Hochberg) to remove false positives. Lists were compiled for genes expressed differentially in pair-wise comparisons of MK variants or primary cultures of different genotype. The complete gene list was submitted to Gene Expression Omnibus (series GSE42041).

α3β1-dependent genes identified by microarray were validated using custom qPCR arrays (SABiosciences, Valencia, CA), designed to include 87 genes that were differentially expressed on the microarrays, 2 house keeping controls (ACTB and GAPDH), and controls for evaluating mouse genomic DNA contamination, reverse transcription, and a positive control for qPCR. Total RNA (2 μg each from three independent experiments) was reverse transcribed using reagents kits from SABiosciences, and resulting cDNAs (20 ng) were used for qPCR. 384-well plates were run on an ABI 7900HT instrument using standard protocol and data analyzed using templates provided by SABiosciences. Fold changes were determined using the 2\^−(delta Ct) method.

Individual qPCR for fibulin-2 and SPARC was performed using iQ SYBR green Supermix (Bio-rad, Hercules, CA). cDNA was generated using iScript Reverse Transcription Supermix (Bio-Rad). Conditions for fibulin-2: forward primer, 5′-TGTTGTTGGGGACACAGCTA-3′; reverse primer, 5′-CGTCTGTGCATTCACCATCT-3′; 95°C, 10 min, 1 cycle; followed by 94°C, 30 sec; 53°C, 30 sec; 72°C, 30 sec; 40 cycles. Conditions for SPARC: forward primer, 5′-TTCGACTCTTCCTGCCACTT-3′; reverse primer, 5′CCAGTGGACAGGGAAGATGT-3′; 95°C, 10 min, 1 cycle; followed by 94°C, 1 min; 53°C, 1 min; 72°C, 1 min; 40 cycles. Conditions for β-actin: forward primer, 5′-AGGGAAATCGTGCGTGACAT-3′; reverse primer, 5′-CATCTGCTGGAAGGTGGACA-3′; 95°C, 10 min, 1 cycle; followed by 94°C, 1 min; 58°C, 90 sec; 72°C, 90 sec; 35 cycles. Relative mRNA levels were calculated using the formula \[2\^−(Ct target gene − Ct β-actin gene)\] × 100.

Immunoblots {#S12}
-----------

Cells were lysed in non-reducing lysis buffer (Cell Signaling Technology, Beverly, MA) and protein concentrations determined by BCA Protein Assay (Pierce, Rockford, IL). Reducing lysis buffer contained 200 mM dithiothreitol (DTT). Equal protein was assayed by immunoblot with antibodies at the indicated dilutions: rabbit polyclonal anti-α3 integrin, 1:1000 ([@R20]); rabbit polyclonal anti-fibulin-2, 1:1000 (gift from Dr. Mon-Li Chu, Thomas Jefferson University); rabbit polyclonal anti-ERK2, 1:1000 (Santa Cruz, Santa Cruz, CA). Horseradish peroxidase-conjugated secondary antibody was goat anti-rabbit IgG (Cell Signaling, Danvers, MA), 1:2000. Chemiluminescence was performed using SuperSignal chemiluminescent substrate (ThermoScientific, Rockford, IL). Blots were quantitated using Image J software (NIH) or Biorad Imagelab software.

siRNA transfection {#S13}
------------------

Cells were plated in full MK medium on collagen-coated 6-well dishes 24 hours prior to transfection. GenMute siRNA transfection reagent for primary keratinocytes (SignaGen Laboratories, Rockville, MD) was used to transfect cells with 80nM siRNA (Dharmacon Inc, Lafayette, CO). Two days later, cells were lysed for immunoblot or seeded for invasion assays. Of four fibulin-2-targeting siRNAs, we chose two that showed efficient suppression (siRNA \#1-GCGAAGGCUACCAGUACUA, siRNA \#4-CCAAUAGCCUGCCGGGAGA). siRNA against luciferase was used as control.

Matrigel invasion assays {#S14}
------------------------

Cells (8 × 10^4^) were seeded onto growth factor-reduced Matrigel invasion chambers (8 μm pore; BD Biosciences, San Jose, CA) in MK medium without interferon-γ. Cells were allowed to invade for 16 h, then fixed in 3.7% formaldehyde. Cells that invaded through the filter were permeabilized in 0.05% triton X-100, stained with 4′,6-diamidino-2-phenylindole (DAPI; 1 μg/ml), and quantified manually by imaging four fields/well at 20X magnification on a Nikon eclipse TE2000-U inverted microscope. Data are from 4 experiments, each performed in duplicate.

Lentiviral transduction with shRNA {#S15}
----------------------------------

pGIPZ lentiviral vectors containing fibulin-2-specific shRNA sequences or non-targeting control shRNA were purchased from Thermo Scientific Open Biosystems (Lafayette, CO). 293FT packaging cells were co-transfected with packaging plasmids pCMV-dR8.2 and pCMV-VSV-G (Addgene plasmids 8455 and 8454). TMK cells were infected with viral particles plus antennapedia peptide (Anaspec, Fremont, CA), and stable transductants were selected in 10 μg/ml puromycin.

Gelatin zymography {#S16}
------------------

Cells (4 × 10^5^) were plated onto collagen coated 6-well dishes in full MK medium overnight, then washed and cultured in 2 ml serum-free medium without antibiotics for 24 hours. Culture medium was collected and incubated with gelatin-agarose beads (Sigma) overnight, then assessed by gelatin zymography, as described ([@R21]).

Subcutaneous injections {#S17}
-----------------------

TMK cells (5 × 10^6^) were suspended in 200 μl complete MK medium and injected into right flanks of 10--12 female NCR nude mice per test group (Taconic, Hudson, NY). Tumor length (l) and width (w) were measured over 23 days using a Vernier caliper (Bel-Art Scienceware). Tumor volume was estimated using the formula (w^2^ × l)/2. Statistical analysis was performed by first averaging tumor size from the last three time points for each TMK variant, then using one-way ANOVA with Dunnett's post-test to compare each TMKα3+/+ variant (i.e., transduced with control or fibulin-2-targeting shRNA) to the TMKα3−/− control. Animal studies were approved by the Institutional Animal Care and Use Committee of Albany Medical College.
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![qPCR validation of α3β1-dependent genes in immortalized MK cells. A subset of α3β1-regulated genes identified by microarray analysis ([Fig. S1](#SD1){ref-type="supplementary-material"}) was analyzed by qPCR. Analysis was focused on a selection of genes confirmed as α3β1-dependent through restoration of original expression levels in MK−/− cells following stable expression of human α3. (a, b) Graphs depict gene expression changes as fold decrease (negative value) or increase (positive value) in (a) MK−/− cells or (b) MK−/−:hα3 cells, each relative to MK+/+ cells. (c) Summary of changes in genes that are down-regulated or up-regulated in MK−/− cells compared to MK+/+ cells. Data are mean of three experiments; P values calculated based on Student's t-test of replicate 2\^(−Delta Ct) values for each gene in control group and treatment groups.](nihms580381f1){#F1}

![α3β1 regulates gene expression of fibulin-2, but not SPARC, in p53-null immortalized IMK cells and RasV12-transformed TMK cells. (a) Chart indicates the genetic lesion(s) that were used to effect the immortalization or transformation of different mouse keratinocyte-derived cell lines (see text for details). (b--e) Graphs show qPCR analysis of (b, d) fibulin-2 (Fbln-2) or (c, e) SPARC gene expression in (b, c) IMK cells that either express α3β1 (IMKα3+/+) or lack α3β1 (IMKα3−/−), or (d, e) derivatives of the latter cells that are transformed with RasV12 (TMKα3+/+ and TMKα3−/−). Relative qPCR signals are shown after normalization to those for β-actin mRNA. Data are shown as mean ± s.e.m. for three separate experiments; \*P\<0.05, unpaired t-test.](nihms580381f2){#F2}

![Absence of α3β1 is associated with reduced fibulin-2 protein. (a) Total lysates from LTAg-immortalized MK+/+ cells, MK−/− cells, or MK−/−:hα3 cells were resolved on non-reducing or reducing gels and immunoblotted with anti-fibulin-2 (Fbln-2, top), or anti-ERK2 (bottom) as loading control. Arrows indicate positions of disulfide-linked homodimeric and monomeric fibulin-2. Molecular weight markers shown at left. (b) Graph shows quantification in MK cells of total fibulin-2 (dimeric plus monomeric), normalized to ERK-2. Data are mean ± s.e.m.; n=4; one-way ANOVA, \*P\<0.05; Tukey's multiple comparison; ns, not significant. (c) Cell lysates (non-reduced) from p53-null immortalized MK cells (IMKα3+/+ or IMKα3−/−) or RasV12-transformed cells (TMKα3+/+ or TMKα3−/−) were immunoblotted as above; representative of three experiments. Relative signal intensity for total fibulin-2, normalized to ERK-2, is listed below lanes.](nihms580381f3){#F3}

![Knockdown of fibulin-2 leads to reduced invasion of IMKα3+/+ and TMKα3+/+ cells. (a, b) Representative immunoblots show suppression of fibulin-2 (Fbln-2) protein in (a) IMKα3+/+ cells or (b) TMKα3+/+ cells using two distinct siRNAs that target fibulin-2 (si\#1 and si\#4), compared with control siRNA (siCtrl) or untreated cells (untr.); blot for ERK2 served as a loading control. Relative signal intensity for total fibulin-2 (dimeric plus monomeric), normalized to ERK-2, is listed under each lane. Fourth lane in panel (b) is from the same blot as first three lanes. (c, d) Graphs show relative invasion of (c) IMKα3+/+ cells or (d) TMKα3+/+ cells treated with fibulin-2-targeting siRNAs, normalized to cells treated with control siRNA; data are mean ± s.e.m; n=3; \*P\<0.05, two-way ANOVA.](nihms580381f4){#F4}

![Fibulin-2 suppression in RasV12-transformed TMK cells does not inhibit tumor growth. (a) Immunoblot shows fibulin-2 (Fbln-2) knockdown in TMKα3+/+ cells transduced with two shRNAs, compared with control shRNA (ctrl). Relative signal intensity for total fibulin-2, normalized to ERK-2, is listed under each lane. (b) TMKα3−/− or TMKα3+/+ cells transduced with indicated shRNA were injected subcutaneously into nude mice. Graph shows average tumor volume ± s.e.m. over 23 days for each variant. TMKα3+/+ with ctrl shRNA, n=12; others, n=10. Each TMKα3+/+ variant showed a significant increase in tumor size (averaged over last three time-points) compared with TMKα3−/− cells; \*P\<0.05; one-way ANOVA, Dunnett's post-test. (c) Gelatin zymography of culture medium shows reduced MMP-9 secretion in TMKα3−/− cells compared with TMKα3+/+ cells, but no effect of fibulin-2-targeting shRNAs in the latter cells.](nihms580381f5){#F5}
